USANA Health Sciences Inc. - 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 27, 2003, and the nine months ended on that date. USANA Health Sciences, Inc. develops and distributes nutritional, personal care, and weight management products primarily through a network marketing system of independent "Associates." The company operates two reportable segments: Direct Selling (its principal business) and Contract Manufacturing (commenced July 1, 2003, following the acquisition of Wasatch Product Development, Inc.).
On October 14, 2003, the company declared a two-for-one stock split, distributed as a stock dividend on October 30, 2003. All share data in this report has been adjusted to reflect this split.
Key Financial Metrics
| Metric (in thousands) | Quarter Ended Sep 27, 2003 | Nine Months Ended Sep 27, 2003 |
|---|---|---|
| Net Sales | $52,506 | $140,527 |
| Gross Profit | $41,142 | $109,526 |
| Gross Margin | 78.4% | 77.9% |
| Net Earnings | $6,056 | $13,980 |
| Diluted EPS | $0.28 | $0.66 |
| Cash and Equivalents | $10,335 | $10,335 (Ending Balance) |
| Operating Cash Flow | N/A | $25,669 |
| Long-Term Debt | $0 | $0 |
| Line of Credit | $0 (Unused) | $0 (Unused) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 50.9% for the quarter and 47.2% for the nine months compared to the prior year periods. Growth was driven by a 15.9% increase in the active Associate base, expansion into Taiwan and South Korea, and favorable foreign currency translation.
- Profitability: Net earnings surged 158.5% for the quarter and 168.9% for the nine months. Gross margins improved to 78.4% (quarter) and 77.9% (nine months) due to cost efficiencies and pricing strategy changes.
- Acquisition Impact: The acquisition of Wasatch Product Development, Inc. (WPD) on July 1, 2003, added $656,000 in sales and $25,000 in operating income for the quarter. It also resulted in $4.26 million of goodwill on the balance sheet.
- Balance Sheet: Total assets grew from $39.1 million to $53.1 million. The company paid off all long-term debt and line of credit balances during the period, resulting in zero debt as of September 27, 2003.
Guidance, Outlook, and Risks
- Guidance: Management expects net sales of approximately $57 million for the 14-week fourth quarter ended January 3, 2004. Gross profit margins are expected to approximate the third-quarter level. Associate incentives are projected to be approximately 40% of consolidated net sales for the fourth quarter.
- Outlook: The company anticipates continued growth in active customers and sales leverage. Manufacturing and packaging for the Sensé product line by the new subsidiary are expected to begin in the fourth quarter.
- Risks: Key risks include reliance on the network marketing system, high turnover of Associates, foreign currency fluctuations (53% of sales are international), and regulatory scrutiny of network marketing practices. The company currently has no hedging instruments in place for foreign currency exposure.
- Unusual Items: A significant portion of the increase in "Other Income" ($525,000 for the quarter) was due to foreign currency gains on intercompany balances resulting from a weaker U.S. dollar.
Investor Verification Checklist
- Stock Split Adjustment: Verify that all historical share counts and EPS figures are adjusted for the two-for-one stock split effective October 30, 2003.
- Associate Retention: Monitor the "Active Associate" count and turnover rates, as revenue is heavily dependent on this network.
- Foreign Currency Exposure: Assess the impact of a strengthening U.S. dollar on future earnings, given that over 50% of sales are international and no hedging is currently utilized.
- Acquisition Integration: Track the performance of the Wasatch Product Development, Inc. acquisition and its contribution to the Sensé product line manufacturing.
- Debt Covenants: Confirm continued compliance with the $10 million line of credit covenants, although no debt is currently outstanding.